[Clinical investigation of a combination preparation of ampicillin, theophylline, papaverine-HCl and guaiacolglyceryl ether. 2. In form of syrup].
D000208:Acute Disease; D000293:Adolescent; D000667:Ampicillin / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D000996:Antitussive Agents / Q000627:therapeutic use*; D001314:Auscultation; D001991:Bronchitis / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004304:Dosage Forms; D004338:Drug Combinations; D004341:Drug Evaluation; D006140:Guaifenesin / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D006801:Humans; D007223:Infant; D010208:Papaverine / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D013806:Theophylline / Q000097:blood / Q000627:therapeutic use* / Q000652:urine
D000996:Antitussive Agents; D004304:Dosage Forms; D004338:Drug Combinations; D006140:Guaifenesin; D000667:Ampicillin; D013806:Theophylline; D010208:Papaverine
Klinische Prüfung eines Kombinationspräparates aus Ampicillin, Theophyllin, Papaverin-HCl und Guajakolglycerinäther. 2. Mitteilung: In Form eines Saftes